Lab Automate Technologies Inc

Lab Automate Technologies Inc is a biotechnology and pharmaceutical startup with a mission to accelerate the market entry of inhaled drugs. Established in 2006, the company focuses on developing test automation for inhalation products and precision powder dispensing technologies for pharmaceutical manufacturing. Lab Automate Technologies has applied for global patents for automating the Andersen Cascade Impactor, seeking sponsors to build this system. This innovative technology is expected to increase test throughput by 4x to 6x and reduce the cost per test by half. The firm's last investment was a $50.00K grant investment received on October 23, 2012, backed by MassChallenge. The company is open to licensing this technology and exploring executive engineering opportunities. With a clear focus on improving the efficiency and cost-effectiveness of pharmaceutical testing, Lab Automate Technologies Inc presents an intriguing opportunity for potential investors in the biotech and pharmaceutical industries.